Welcome To Stock Marketing Inc. Check Us Out!! Strong Alerts!! XDSL,STTN,GNXP,HFBG,ISCO,NNVC:: Sign Up Today!!

STOCK MARKETING INC PRESENTS : (OTCBB: XDSL) mPhase Technologies, Inc., (OTCBB: STTN) Smart-Tek Solutions, Inc., (OTCBB: GNXP) Guinness Exploration, Inc., (PINKSHEETS: HFBG) Hall of Fame Beverages, Inc., (OTCBB: ISCO) International Stem Cell Corp., (OTCBB: NNVC) NanoViricides, Inc.

www.StockMarketingInc.com

For More Information email us!! [email protected]

------------------------------------------------------------------------------------------------------------------------------------------------------------

(OTCBB: XDSL - mPhase Technologies, Inc.)

LATEST NEWS!!

mPhase Technologies to Speak at Nanotechnology Symposium at Stevens Institute of Technology on July 26

LITTLE FALLS, NJ, Jul 21, 2010 -- mPhase Technologies, Inc. (OTCBB: XDSL) today announced that it has been invited to give a technical presentation on smart surfaces and the Smart NanoBattery implementation at a technical symposium hosted at Stevens Institute of Technology in Hoboken, New Jersey on July 26, 2010. The symposium will highlight research and development advances that incorporate micro- and nanoscale structures and mechanical electrical microsystems (MEMS) designs.

The workshop, organized and attended by the Tri-State University participants and Picatinny Arsenal, is being held to facilitate communications and collaboration among MEMS/NEMS/nanomanufacturing researchers in the New Jersey and New York City metropolitan area. At the workshop, mPhase will discuss how it has incorporated technical advances it has made to control and manipulate a liquid's interaction on a smart surface, to develop the Smart NanoBattery architecture and how it is using silicon fabrication assembly techniques to create the NanoBattery's hermetically sealed packaging enclosure, an important feature for giving the battery its very long shelf life.

"This workshop is a very good opportunity for mPhase to continue to participate with the technical community and highlights the importance of having small business involvement in New Jersey region," said Ron Durando, president and CEO of mPhase Technologies. "We are looking forward to working with Stevens Institute of Technology to promote research, development and commercialization efforts involving these technologies." About mPhase Technologies, Inc. mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.

In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website: http://www.mpowertech.com.

More information about the company can be found at http://www.mPhaseTech.com.

------------------------------------------------------------------------------------------------------------------------------------------------------------

(OTCBB: STTN - Smart-Tek Solutions, Inc.)

LATEST NEWS!! Smart-Tek Lands $120 Million in Gross Annual Payroll

NEWPORT BEACH, Calif., July 21, 2010 -- Smart-Tek Automated Services, Inc. (OTC Bulletin Board: STTN) announces an agreement signed June 22, 2010 with a Chicago-based broker who is targeting a minimum of $120 million in annual gross payroll with a resulting net reportable revenue (in compliance with GAAP) in excess of $40 million, subject to any adverse market changes. $40 million in annual gross payroll will be processed ($12 million net reportable revenue) by the quarter ending September 30, with the balance placed by quarter ending December 31.

Growing its broker sales network is a strategic priority for Smart-Tek, since brokers serve a critical role in the PEO world as the initial client contact, and the company has signed several new contracts in recent weeks. In addition to offering lucrative broker plans, Smart-Tek's appeal to broker networks results from offering some of the country's most comprehensive PEO offerings. The company's personalized presentations include broker information, submission forms, comparison tools, detailed reports on commissions, detailed reports on variances between booked and actual remarketing processes, and numerous other useful technologies and enhancements.

"We believe the U.S. broker market is critical to the success of PEOs in general and to our company in particular," said Kelly Mowrey, COO of Smart-Tek. "Our strategic plans are targeted right in the sweet spot, and we will continue to build our efforts in attracting them as we expand our market share." Release clarifications: In the July 16, 2010 release, the $20 million in new revenue is gross annual payroll revenue or $6 million in net reportable annual payroll revenue. In the July 19, 2010 release, the reference to business already placed exceeding $10 million, is $10 million in gross annual payroll revenue or $3 million in net reportable annual payroll revenue. In the July 20, 2010 release, the reference to $40 million in gross annual payroll revenue by year's end is $12 million in net reportable revenue by calendar year-end.

Please visit www.smart-tekservices.com for further information.

About Smart-Tek Solutions, Inc.: The parent, Smart-Tek Solutions, Inc., generates revenue from the installation of security systems in construction projects. Its board is currently in negotiations to sell its original business and focus entirely on the PEO business of its wholly owned subsidiary, in order to achieve the best value for its shareholders. The original business generated $3.3 million and $3.8 million of revenue in 2009 and 2008 respectively, and $0 and ($3.1) loss of earnings in 2009 and 2008 respectively.

About Smart-Tek Automated Services, Inc.: Smart-Tek Automated Services, Inc. provides financial services to small and medium-size businesses, relieving its clients from many of the day-to-day tasks that negatively impact their core business operations such as payroll processing, human resources support, workers' compensation insurance, safety programs, employee benefits, and other administrative and aftermarket services predominantly related to staffing: staff leasing, temporary staffing and co-employment. It not only provides core services but a wide selection of employee and employer benefits and aftermarket products.

----------------------------------------------------------------------------------------------------------------------------------------------------------------

(OTCBB: GNXP - Guinness Exploration, Inc.)

LATEST NEWS!! Guinness Exploration Receives Yukon Permit Approvals for Trenching and Drilling at Nantawa Project

WELLINGTON, New Zealand, July 20, 2010 -- Guinness Exploration Inc. (OTC Bulletin Board: GNXP) reported that the Company has received its Class 3 permit for trenching and drilling activities at the Nantawa Project from the Yukon Energy, Mines and Resources licensing authority.

Chief Geologist John Hiner said, "We're extremely pleased to report our Class 3 permit approval, which allows us to begin trenching and drilling operations. We're well prepared for this development. Our camp is fully established and our drill and trenching equipment are currently onsite. We will begin construction of drill pads immediately and the mobilization of our drilling crew. We expect to complete both steps within the next few days and be drilling by week's end." Mr. Hiner continued, "Over the last couple of weeks, we've completed an accurate differential GPS survey and utilized the survey data to locate all known previous trenches, historic drill holes, and other data pertinent to mineralization on the property. The data have been compiled and assembled in our GIS database and the work we've completed on site, which entailed accurate re-location of trench and drill hole data, has allowed us to accurately define the location of previously delineated mineralized zones." Mr. Hiner concluded, "Based on our work to date, we have established several gold and silver drill targets and have mapped the exact coordinates for additional trenching and our initial drill program. Trenching is planned to confirm and extend mineralized zones. Confirmation and step out drill holes have also been planned and staked and we'll initiate drilling once our crew is deployed onsite." About Guinness Exploration Guinness Exploration Inc. trades on the OTC-BB under the symbol GNXP. The Company was incorporated in Nevada in 2005 and incorporated its subsidiary Nantawa Resources Inc. in Yukon, Canada in 2009. In November, 2009, Guinness entered an agreement to acquire mineral claims for the Mount Nansen and the Tawa gold and silver exploration properties (collectively the 'Nantawa Project') in the Yukon and is now developing an exploration program. The Nantawa Project is situated in the prolific Tintina Gold Belt, a 1,200 km long area extending from northern British Columbia, through the Yukon Territory and into southwest Alaska. The Tintina Gold Belt includes such world-class, multi-million ounce gold deposits as Pogo, Fort Knox, True North, and Donlin Creek. The Nantawa Project claims consist of 203 full or fractional claims with a total area of 3,136.43 square hectares located in the South Central part of the Yukon, 180 km Northwest of Whitehorse and 60 km west of the Village of Carmacks. A complete independent geological report received by Guinness, dated November 27, 2009, can be viewed on Guinness' website: www.guinnessexploration.com.

------------------------------------------------------------------------------------------------------------------------------------------------------------

(PINKSHEETS: HFBG - Hall of Fame Beverages, Inc.)

LATEST NEWS!! Hall of Fame Beverages Ready to Begin July Production and Distribution

LOS ANGELES, CA, Jul 21, 2010 -- Hall of Fame Beverages, Inc. (PINKSHEETS: HFBG) announces production of its anchor brand Atomic Dogg Super Soda and its newest brand Grand Ma Ma's Sweet Southern Tea will take place over the next week and a half. HFBG president Calvin Ross said, "We have been working feverishly to finalize our production plans, to set up our distribution network, to get our new 20 .oz plastic bottles to the manufacturer and to get Kosher Certified. Needless to say, we're excited production is finally here and distribution is on the doorstep." After production, the company's brands will then be immediately shipped and placed into the new distribution network. Ross said, "We will get our products out immediately after production, and we'll have the very last of the more than 30,000 cases, in this July production run, on shelves by mid-August." In HFBG's upcoming distribution, Atomic Dogg Super Soda and Grand Ma Ma's Sweet Southern Tea will be sent to such areas as North Carolina, Virginia, West Virginia, Maryland, New York State, as well as all of New York City, Texas, Washington, D.C., Connecticut, Illinois and Michigan just to name a few. Ross said, "We'll be getting great coverage with this distribution and getting our brands to different states and different distribution locations at supermarkets and into the box stores in our extensive distribution network." The company has received its Kosher Certification, and the certificates can be found on the company's website http://www.halloffamebeverages.com/grandmama_sweet_tea.html.

Also on the site, we included pictures of the new 20 .oz plastic bottles with the Kosher designation on the bottles, and a copy of the sales order for the ingredients shipped to the manufacturer for our Atomic Dogg Super Soda.

Calvin Ross has been working diligently over the past two and a half weeks to interview and carefully consider the make-up of the company's new management team. Ross said, "Our new CEO and a new COO will be announced next week. In addition to the new distribution network we'll be using for our brands, our new COO brings with him strong distribution channels as well. He has us negotiating the final price schedule to place our products with more than 800 franchisee 7-11 owners throughout Nevada, Arizona and California.

About Hall of Fame Beverages Hall of Fame Beverages, Inc. (www.halloffamebeverages.com) is a new lifestyle company dedicated to building long-term success through the creation, manufacture, distribution, and marketing of innovative non-alcoholic beverages recognized for their fresh, standout brand identities that rise above the plethora of average products. Hall of Fame Beverages is a team of visionary and seasoned beverage industry executives who intend to leverage their expertise and their established resources in beverage commerce to make Hall of Fame Beverages one of the industry's big winners via its signature brands Atomic Dogg Super Soda and Grand Ma Ma's Sweet Southern Tea.

------------------------------------------------------------------------------------------------------------------------------------------------------------

(OTCBB: ISCO - International Stem Cell Corp.)

LATEST NEWS!! International Stem Cell Corporation and Insight Bioventures Seek to Establish Indian Operations

OCEANSIDE, Calif. & HYDERABAD, India, Jul 20, 2010 -- International Stem Cell Corporation (OTCBB: ISCO), and Insight Bioventures India Private Limited, announced today that they have signed a letter of intent concerning funding and establishment of an Indian affiliate of ISCO (ISCO India). The goal is to establish world-class development and manufacturing operations for ISCO's research and pharmaceutical products in India, including its Lifeline Cell Technology(R) research products and human corneal tissue, CytoCor(TM), for treatment of corneal vision impairment and testing of chemicals. IBVI is an experienced biomedical business facilitator with a solid network among Indian corporations, academia and government. In collaboration with Sristi Biosciences (www.sristibio.com), a full-fledged developer, manufacturer and commercial operation and the therapeutic arm of Indian bio industry leader Sri Bio (www.sribio.com), IBVI facilitated the earliest submissions and approvals of the stem cell therapy guidelines of India. Some of IBVI's major collaborators include ophthalmology research center and hospital, Sankara Nethralaya (www.sankaranethralaya.org), The Centre for Cellular and Molecular Biology (a federally funded institute run by the Indian government, www.ccmb.res.in), the All-India Institute for Medical Sciences (www.aiims.edu), and the Indian Council for Medical Research (www.icmr.nic.in). IBVI has established a dedicated Biofund to finance novel businesses in India.

According to Dr. Jayaraman Packirisamy, Executive Director of IBVI, "ISCO offers our investors as well as corporate and academic partners a unique combination of Lifeline marketed research products with near-term revenue potential in India, CytoCor with potential to change standard of care for the widespread corneal blindness and vision impairment in India and the rest of Asia, and an opportunity to apply our well-educated work force and industrial grade facilities to develop and manufacture these and other biomedical products cost-efficiently in India. We therefore look much forward to lead the funding and implementation of ISCO India." Dr. Gopal Pande, managing scientist at The Centre for Cellular and Molecular Biology adds, "Our institution is a leader in cell biology in India and, while we have been involved with a wide range of opportunities in this field, we believe CytoCor represents a rare opportunity to produce functional, live human tissue from individual cells. We are keen to explore the possibilities with ISCO and IBVI and hope to not only apply our scientific expertise but also to host ISCO in India's first, state-of-the art, $60M, integrated research and clinical development facility for stem cells and regenerative medicine, CRF, established in collaboration between the CCMB and the Nizam's Institute of Medical Sciences." Under the letter of intent, IBVI will lead the funding and establishment of ISCO India with facilities and staff. ISCO will train Indian scientists and commercial staff and provide rights to the company's technologies, products and intellectual property as needed. ISCO India will be managed by a combined team of experienced development and business executives from IBVI and Sristi Biosciences in India and senior executives of ISCO in the US. ISCO India will be based in Hyderabad and continue to work closely with the leading team of ophthalmology scientists and clinicians at Sankara Nethralaya in Chennai as well as researchers and government bodies across India. Formal details of this arrangement are expected to become the subject of a definitive agreement in the near future.

"IBVI and their corporate, academic and government network provide ISCO with an unparalleled opportunity to tap into the rapidly growing research product market in India and develop CytoCor with a team of experienced scientists and clinicians in the country with most corneal blindness and vision impairment in the world. Furthermore, IBVI's Biofund investors enable us to do so without ISCO capital investment or issuance of equity shares. Finally, by establishing our own affiliate in India, ISCO will be able to participate in the economic benefits of our technologies and products while retaining the intellectual property control that is so important across Asia," says Brian Lundstrom, ISCO's President.

ABOUT INTERNATIONAL STEM CELL CORPORATION International Stem Cell Corporation is a California-based biotechnology company focused on therapeutic and research products. ISCO's core technology, parthenogenesis, results in creation of pluripotent human stem cells from unfertilized oocytes (eggs). These proprietary cells avoid ethical issues associated with use or destruction of viable human embryos and, unlike most other major stem cell types, can be immune matched and be a source of therapeutic cells with minimal rejection after transplantation into hundreds of millions of individuals of differing racial groups. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary, Lifeline Cell Technology, and is developing a line of cosmeceutical products via its subsidiary, Lifeline Skin Care. ISCO is advancing novel human stem cell-based therapies where cells have been proven to be efficacious but traditional small molecule and protein therapeutics have not. More information is available on ISCO's website.

------------------------------------------------------------------------------------------------------------------------------------------------------------

(OTCBB: NNVC - NanoViricides, Inc.)

LATEST NEWS!! Nanoviricides(R) Anti-Ebola Results Presented at Annual Meeting of the American Society for Virology by USAMRIID Scientist

WEST HAVEN, Conn., Jul 19, 2010 -- NanoViricides, Inc. (OTCBB: NNVC) reports that the results of the evaluation of several of its nanoviricides(R) anti-Ebola agents were presented July 17th at the Annual Meeting of the American Society for Virology, July 17-21, at Montana State University, Bozeman, MT. Dr. Corinne Scully delivered the presentation, which was entitled "Polymeric Micelle Nanomaterials as Antiviral Compounds For Ebola Virus Infection." The studies were performed in the laboratory of Dr. Gene Olinger at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD.

In cell culture screening assays, the nanoviricides(R) were evaluated for cytotoxicity and for inhibition of Ebola virus infection. Several of the nanoviricides demonstrated a dose-dependent inhibition of Ebola virus infectivity with no toxicity of uninfected cells at concentrations that were effective against the virus.

A subset of the nanoviricides that were effective in cell culture was selected for testing in vivo in a mouse model of Ebola infection. The compounds were well tolerated by the animals and showed some efficacy against the mouse-adapted Ebola virus. Efficacy of nanoviricides treatment against Ebola virus was demonstrated by an increase in lifespan in this uniformly 100% lethal animal model.

The Company developed a library of chemical ligands that were expected to bind to the Ebola virus envelope proteins. The results reported at this meeting will help guide the synthesis of next generation anti-Ebola nanoviricides in a lead optimization synthetic program. Optimized nanoviricides will also be evaluated against other similar Hemorrhagic Fever Viruses, e.g. Marburg virus.

Based on the current results and previous success with another hemorrhagic fever virus (viz. Dengue), the Company believes that it can develop a single nanoviricide drug that is highly effective against both Ebola and Marburg filoviruses. Developing a single drug against the various Ebola and Marburg viruses has been a major challenge for researchers in the field. Currently there are no approved vaccines or therapeutics for the prevention or treatment of Ebola and Marburg viruses.

Ebola/Marburg viruses are a major concern both as potential global health threats and as potential threat agents for Biosecurity and Biodefense, and are identified as Category A agents. Ebola outbreaks have resulted in fatality rates as high as 80% in humans (http://www.who.int/mediacentre/factsheets/fs103/en/index.html).

About NanoViricides: NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide(TM) class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral diseases including H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others.

------------------------------------------------------------------------------------------------------------------------------------------------------------

About StockMarketingInc.com

StockMarketingInc.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by StockMarketingInc.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.

((Comments on this story may be sent to [email protected]))